Key findings of IMPACC study could enhance prevention and treatment of Long COVID

This study collected immune responses from nearly 600 patients hospitalized for COVID-19, including 12 months of follow up to determine possible causes and risk factors of long COVID. This work is important as it can lead to new treatments for long COVID, and early identification of patients at high risk. Co-author Catherine L. Hough, MD was funded by the COVID-19 Respiratory Virus Research Award.